Hikal Ltd.

NSE: HIKAL | BSE: 524735 | ISIN: INE475B01022 | Industry: Pharmaceuticals
| Falling Comet
226.9700 -1.04 (-0.46%)
NSE Dec 30, 2025 15:31 PM
Volume: 391.4K
 

logo
Hikal Ltd.
19 Sep 2018
226.97
-0.46%
ICICI Securities Limited
We met the management of Hikal Ltd (Hikal) to gain an insight into the company's pharma and agrochem businesses. Established in 1988, Hikal is a B2B player, which provides active ingredients, intermediates and R&D; services to global pharmaceuticals, animal health, crop protection and specialty chemicals companies. For FY18, pharma and agrochem accounted for 58% and 42%, respectively, of total operating revenues. The pharma business is currently divided almost equally between generic active pharma ingredients (APIs) and contract research and...
Hikal has lost -37.47% in the last 6 Months
More from Hikal Ltd.
Recommended